Clinical Trials Logo

Filter by:
NCT ID: NCT02511834 Completed - Clinical trials for Coronary Artery Disease

VEST III PMS Clinical Protocol

VEST III
Start date: October 19, 2015
Phase: N/A
Study type: Interventional

Post marketing surveillance (PMS) study. 200 patients will be enrolled in a prospective, multi center, randomized, two-arm, open label, and controlled, enrolling patients with multi vessel atherosclerotic coronary artery disease, scheduled to undergo Coronary artery bypass grafting (CABG) with arterial grafting of IMA to LAD, one saphenous vein graft (SVG) to the right territory and one or more SVGs to the left territory. Of all vein grafts, one will be selected randomly to receive treatment with VEST and another designated Control.

NCT ID: NCT02511405 Completed - Glioblastoma Clinical Trials

A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)

GLOBE
Start date: August 2015
Phase: Phase 3
Study type: Interventional

The purpose of this pivotal, phase 3, randomized, multicenter study is to compare VB-111 plus bevacizumab to bevacizumab in adult patients with recurrent Glioblastoma.

NCT ID: NCT02511223 Completed - Pancreatic Cancer Clinical Trials

Efficacy and Safety of PARPi to Treat Pancreatic Cancer

10
Start date: July 2016
Phase: Phase 2
Study type: Interventional

This is an open label, single arm, phase II trial of Olaparib for (PDAC) pancreatic ductal adenocarcinoma patients with BRCAness (breast cancer gene). All study subjects will receive Olaparib in a dose of 300 mg p.o twice daily. Treatment will continue until progression, intolerable toxicity or as per patient preference. Primary objective: To determine the efficacy of Olaparib monotherapy in stage IV pancreatic ductal adenocarcinoma (PDAC)with (BRCAness) BRCA -Breast Cancer susceptibility gene.

NCT ID: NCT02511106 Active, not recruiting - Clinical trials for Stage IB-IIIA Non-small Cell Lung Carcinoma

AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.

ADAURA
Start date: October 21, 2015
Phase: Phase 3
Study type: Interventional

To assess the efficacy and safety of AZD9291 versus Placebo, in patients with Epidermal Growth Factor Receptor Mutation Positive stage IB-IIIA non-small cell lung carcinoma, following complete tumour resection with or without adjuvant chemotherapy

NCT ID: NCT02510560 Active, not recruiting - Clinical trials for Premature Birth of Newborn

Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

Start date: December 2016
Phase: Phase 3
Study type: Interventional

The study will evaluate the effect of NTRA-2112 on intestinal malabsorption in preterm infants.

NCT ID: NCT02510326 Completed - Clinical trials for Wrist Osteoarthritis

Evaluation of Motion in the Arthritic Wrist Joint

Start date: October 2015
Phase: N/A
Study type: Observational

The scaphotrapeziotrapezoid (STT) joint is a dome shaped joint in the radial wrist that is important in transfer of load from the thumb and radial hand to the scaphoid and the radioscaphoid and scaphocapitate joints. Arthritis in this joint is the second most common degenerative arthritis in the wrist, reported in 15% of wrist radiographs. The true incidence of arthritis in the STT joint however is unknown though we assume that most cases of arthritis are not clinically significant. Furthermore, the clinical and biomechanical significance of arthritis in this joint is unclear. The investigators' clinical impression is that the incidence of STT joint arthritis is inversely related to that of radiocarpal joint arthritis. In an ongoing study, we are examining the relationship between STT joint arthritis and radiocarpal joint arthritis on radiographs. We suggest that STT joint arthritis alters the biomechanics of the wrist by limiting movement of the scaphoid within the STT joint thereby protecting the wrist from radiocarpal arthritis by limiting instability of the scaphoid. The specific aims of this pilot study are to evaluate the movement of the arthritic scaphoid within the STT joint using a computer-generated model based on CT scan of the wrist and to compare this model with the already established model of the normal STT joint. The investigators' hypothesis is that there is significantly less motion in the arthritic STT joint.

NCT ID: NCT02510170 Completed - Clinical trials for Maternal-Fetal Relations

Fetal and Maternal Head Circumference During Pregnancy in Israeli Population

Start date: September 2015
Phase: N/A
Study type: Observational [Patient Registry]

In this study, measurements of fetal and maternal head circumference will be collected. This data will be presented in table or graph form. The effect of maternal head circumference on fetal head circumference will be evaluated and presented in either formula or graph form.

NCT ID: NCT02508714 Active, not recruiting - Clinical trials for Coronary Artery Disease

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents

BIONYX
Start date: October 7, 2016
Phase: N/A
Study type: Interventional

The introduction of drug-eluting stents (DES) in the treatment of coronary artery disease has led to a significant reduction in morbidity. However, the first generation of these devices had no positive impact on the mortality after PCI (compared to bare metal stents), which was greatly attributed to a somewhat increased incidence of late and very late stent thrombosis. Concerns about the role of durable polymers as a potential trigger of inflammation and finally adverse events also led to the development of DES with bioresorbable coatings, which leave after degradation of the coating only a bare metal stent in the vessel wall that does not induce an inflammatory response. While such bioresorbable polymer DES are increasingly used in clinical practice, data from head-to-head comparisons between bioresorbable polymer DES with a contemporary highly flexible new generation permanent polymer coated DES.

NCT ID: NCT02507830 Recruiting - Inguinal Hernia Clinical Trials

Mesh Fixation With a Synthetic Glue in Primary Inguinal Hernia Repair

Start date: August 2015
Phase: N/A
Study type: Observational

Prospective observational study with mesh fixation using FDA approved synthetic glue,glubran 2 and standard mesh fixation with stiches in primary inguinal hernia repair surgery. The investigators aim is to recruit 150 patients for the study. The outcomes The investigators would like to determine are : postoperative pain,recurrences and complication rates such as seromas.

NCT ID: NCT02507778 Recruiting - Lung Cancer Clinical Trials

Circulating Tumor Cells Spillage After Pulmonary Biopsy

Start date: September 2015
Phase: N/A
Study type: Interventional

The aim of this study is to quantify the spillage of tumor cells after biopsy in early lung cancer.